Harmony Biosciences Holdings, Inc.
NASDAQHRMY heads into its August 4 Q2 earnings release with short sellers making a clear statement over the past week. Short interest has climbed nearly 10% in seven days to roughly 9% of the free float — the sharpest weekly build in recent months, reversing a longer-term decline that had cut positions by 13% over the prior month. The acceleration began around July 23, when covered…
HRMY short interest falls 21.8% in one week to 8.05% of float, lowest level since early June.
Snapshot as of 1 Aug 2026
HRMY heads into its August 4 Q2 earnings release with short sellers making a clear statement over the past week. Short interest has climbed nearly 10% in seven days to roughly 9% of the free float — the sharpest weekly…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HRMY — free to start on ORTEX.
Sign up for free →Open HRMY on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live HRMY data →